Drug Shortage Report for PAPAVERINE HYDROCHLORIDE INJECTION USP
| Report ID | 158046 |
| Drug Identification Number | 00009881 |
| Brand name | PAPAVERINE HYDROCHLORIDE INJECTION USP |
| Common or Proper name | PAPAVERINE HCL |
| Company Name | SANDOZ CANADA INCORPORATED |
| Market Status | MARKETED |
| Active Ingredient(s) | PAPAVERINE HYDROCHLORIDE |
| Strength(s) | 65MG |
| Dosage form(s) | LIQUID |
| Route of administration | SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR SUBCUTANEOUS INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 2ML 10LIVI |
| ATC code | A03AD |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Shortage of an inactive ingredient or component. |
| Anticipated start date | |
| Actual start date | 2022-02-11 |
| Estimated end date | |
| Actual end date | 2022-08-19 |
| Shortage status | Resolved |
| Updated date | 2022-09-27 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 110 RUE DE LAUZON BOUCHERVILLE, QUEBEC CANADA J4B 1E6 |
| Company contact information | 1 800-361-3062 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-04-06 | English | Compare |
| v2 | 2022-04-06 | English | Compare |
| v3 | 2022-04-06 | French | Compare |
| v4 | 2022-04-06 | English | Compare |
| v5 | 2022-04-06 | French | Compare |
| v6 | 2022-04-20 | English | Compare |
| v7 | 2022-04-20 | French | Compare |
| v8 | 2022-04-29 | English | Compare |
| v9 | 2022-05-05 | English | Compare |
| v10 | 2022-05-05 | French | Compare |
| v11 | 2022-05-24 | English | Compare |
| v12 | 2022-05-24 | French | Compare |
| v13 | 2022-06-17 | English | Compare |
| v14 | 2022-06-17 | French | Compare |
| v15 | 2022-07-14 | English | Compare |
| v16 | 2022-07-14 | French | Compare |
| v17 | 2022-07-14 | English | Compare |
| v18 | 2022-07-14 | French | Compare |
| v19 | 2022-08-18 | English | Compare |
| v20 | 2022-08-18 | French | Compare |